INS and hyperlipidemia: Glycolysis/gluconeogenesis and tricarboxylic acid circulating metabolites are associated with T2D (Guasch-Ferré et al., 2020), and citrate is reported (Yadikar et al., 2022) to modulate insulin sensitivity for further treatment of hyperlipidemia-induced glucose metabolism disorders.